The Latest in AML

DNA sequencing could help identify relapse risk in treated AML

January 4, 2018

AML

Sorafenib plus chemo prolongs event-free survival in AML

January 3, 2018

AML

VIDEO: Joint FDA-ASH session highlights new AML drugs

December 14, 2017

AML

Azacitidine maintenance improves PFS in older AML patients

December 11, 2017

AML

Flu vaccine did not protect children with acute leukemia

December 11, 2017

Levofloxacin prophylaxis in AML reduces febrile neutropenia admissions

December 1, 2017

Researchers identify potential gene target for AML drug development

November 28, 2017

AML

Novel agent to be studied in relapsed/refractory AML

November 20, 2017

AML

Start with fitness when deciding on treatment for elderly AML patients

November 20, 2017

AML

AML candidate drug back in the pipeline

November 9, 2017

AML

Adequately nourished AML patients have survival advantage

November 3, 2017

AML

‘Year of AML’ just the beginning, expert says

October 26, 2017

AML

AML patients overestimate treatment risk and chance of cure

October 25, 2017

October 12, 2017

AML

Minimal residual disease measures not yet impactful for AML patients

October 12, 2017

AML